Menstrual Abnormalities Strongly Associated with Proximity to COVID-19 Vaccinated Individuals

Authors

  • Sue E. Peters† Independent Researcher, New York, NY
  • Jill Newman† Independent Researcher, Mount Pleasant, SC
  • Heather Ray Science and Research Assistant, Children’s Health Defense, Franklin Lakes, NJ
  • James A. Thorp Maternal-Fetal Medicine Physician and Independent Researcher, Gulf Breeze, FL
  • Tiffany Parotto Director and Founder of MyCycleStoDirector and Founder of MyCycleStory℠, Research Analyst, St Petersburg, FL℠, Research Analyst, St Petersburg, FL
  • Brian Hooker Chief Scientific Officer, Children’s Health Defense, Franklin Lakes, NJ, and member of the Editorial Board for the IJVTPR
  • Dan McDyer MD, Private Practice Obstetrician/Gynecologist, Jacksonville, FL
  • Leonard Murphy Research Advisor, LMC Group, Windsor, KY
  • Raphael B Stricker MD at Union Square Medical Associates, San Francisco, CA
  • Maureen McDonnell Registered Pediatric Nurse, Retired, Barnardsville, NC
  • Paul J. Mills Professor, Public Health and Family Medicine, University of California, San Diego, CA
  • Warren Gieck Research Data Analyst, Austin, TX
  • Christiane Northrup Former Fellow of the American College of Obstetrics and Gynecology, Former Assistant Clinical Professor of Obstetrics and Gynecology at the University of Vermont College of Medicine, Portland, ME
  • †The two lead authors contributed equally.

DOI:

https://doi.org/10.56098/tp99wn15

Keywords:

abnormal menses, COVID-19 shedding, COVID-19 transmission, COVID-19 vaccines, menses irregularities, menstrucal bleeding, mRNA spike protein, mRNAvaccines

Abstract

In Spring 2021, MyCycleStorySM launched a secure online survey to which 92.3% of 6049 respondents self-reported menstrual irregularities occurring after the rollout of the COVID-19 injectables. Each respondent served as her own control because prior to the rollout of COVID-19 vaccination, the vast majority had regular menstrual cycles. A subgroup of 3390 respondents were only indirectly exposed to COVID-19 vaccines or the SARS-CoV-2 virus. This subgroup reported 1) being unvaccinated for COVID-19; 2) having had no COVID-19 symptoms; and 3) no positive test for COVID-19, yet a substantial majority of these women, who were only indirectly exposed to COVID-19 injectables or COVID-19 infections still had many of the same menstrual abnormalities as the 2659 women who were directly exposed to a COVID-19 injection (798), or had COVID-19 symptoms (1347), or tested positive for COVID-19 (514). Generalized linear mixed modeling was used to examine the association (not assuming causation) between abnormal menses experienced after the COVID-19 vaccine rollout by respondents who were only indirectly exposed by some degree of proximity to persons. Chi-Square, Student’s t, Kruskal-Wallis or ANOVA tests were used to assess the statistical significance of the similarities of menstrual irregularities reported by the directly exposed and indirectly exposed groups. The mean age of the entire cohort was 37.8 ± 0.1 years. The percentage of the indirectly exposed participants who reported being within 6 feet of a COVID-19 vaccinated person was 85.5%. Of these, 71.7% had irregular menstrual symptoms within one week and 50.1% had irregular menstrual symptoms within ≤3 days after exposure. When comparing daily proximity to a vaccinated person, the categories of “daily within 6 feet outside the household” versus “seldom/sometimes/daily outside 6 feet” had the highest relative risk at 1.34 (p<0.01) for heavier menstrual bleeding, early menses at more than 7 days early with a relative risk at 1.28 (p=0.03), and extended bleeding for more than 7 days with relative risk at 1.26 (p=0.04). Indirect exposure to COVID-19 vaccinated persons was significantly associated with the likelihood of the onset of menstrual irregularities.  This study provides additional data to complement a growing body of evidence raising concerns regarding the safety of mRNA vaccines.

Author Biographies

  • Sue E. Peters†, Independent Researcher, New York, NY

    Peters holds a PhD in behavioral neuroscience from Rutgers University focusing research on sleep, cognition, development, and aging; formerly worked as Senior Researcher at Children’s Health Defense where in addition to researching vaccine injuries and women’s health; some of her published research is available at  https://www.researchgate.net/profile/Sue-Peters-4/research; ORCID: https://orcid.org/0000-0002-4109-6323.

  • Jill Newman†, Independent Researcher, Mount Pleasant, SC

    Newman is an analyst/biostatistician with more than 75 peer-reviewed publications in medical journals; has worked on both epidemiological studies and randomized clinical trials in two major US academic institutions; has taught math and statistics in post-secondary institutions; has been a small business owner and is active in social and civic organizations; is pursuing truth in health outcomes/methodologies and medical health freedom; dedication to such purposes is owed to her devotion to her children and grandchildren.ORCID: https://orcid.org/0000-0001-5156-9529

  • Heather Ray, Science and Research Assistant, Children’s Health Defense, Franklin Lakes, NJ

    Heather Ray is a scientific researcher, analyst, and administrator in the Science and Research Department at Children’s Health Defense; has background in sociology, biology, and massage therapy. She is honored to partner with colleagues on published scientific research and writing projects on vaccine safety, childhood health, and medical freedom; is a voice for those who cannot speak for themselves, and wife of an incredible husband and the mother of five wonderful children.

  • James A. Thorp, Maternal-Fetal Medicine Physician and Independent Researcher, Gulf Breeze, FL

    Thorp, MD, is an actively practicing with 45 years of clinical experience; is extensively published and has testified as an expert in many formal venues including twice in the US Senate; recipient of numerous awards including ones from his professional organizations.

  • Tiffany Parotto, Director and Founder of MyCycleStoDirector and Founder of MyCycleStory℠, Research Analyst, St Petersburg, FL℠, Research Analyst, St Petersburg, FL

    An accomplished marketing and strategy leader who has made significant contributions is also founding/developer of MyCycleStory, a 501(c)(3) nonprofit organization;  dedicated to empowering women’s health and fertility through independent research and impactful projects; expertise in crafting narratives that resonate; has a deep-rooted commitment to her two daughters motivated to create a better future for them and for all children.

  • Brian Hooker, Chief Scientific Officer, Children’s Health Defense, Franklin Lakes, NJ, and member of the Editorial Board for the IJVTPR

    Hooker, PhD, is the Chief Scientific Officer for Children's Health Defense and Professor Emeritus of Biology at Simpson University in Redding, California; coauthor of more than 80 peer-reviewed science and engineering papers in vaccine injury epidemiology and biotechnology in internationally recognized peer-reviewed journals; holds five US patents; and is a member of the Editorial Board of the International Journal of Vaccine Theory, Practice, and Research; ORCID: https://orcid.org/0000-0003-2010-1899

  • Dan McDyer, MD, Private Practice Obstetrician/Gynecologist, Jacksonville, FL

    Board-certified OB/GYN in private practice; member of the Clinical Governance Board of the largest group of OBGYN’s in the US since 2013; served as a Section Chairman for the American College of OBGYNs; President of the Advanced Biological Research Group, Inc.

  • Leonard Murphy, Research Advisor, LMC Group, Windsor, KY

    With 25+ years in market research, Leonard Murphy is a globally recognized thought leader and advisor, leveraging extensive leadership and advisory experience as CEO of successful companies to drive innovation and impactful insights.

  • Raphael B Stricker, MD at Union Square Medical Associates, San Francisco, CA

    Stricker is the medical director of Union Square Medical Associates in San Francisco;  internationally recognized as a leader in tick-borne disease diagnosis, treatment, and research (ORCID: https://orcid.org/0000-0003-2149-8517)

  • Maureen McDonnell, Registered Pediatric Nurse, Retired, Barnardsville, NC

    McDonnell is a retired pediatric registered nurse in which capacity she worked for more than 40 years; was the national coordinator of the Defeat Autism Now conferences; is the founder and Executive Director of Millions Against Mandates, an organization focused on  building collaboration in the health freedom movement and creating solutions for optimizing children’s health and well being.

  • Paul J. Mills, Professor, Public Health and Family Medicine, University of California, San Diego, CA

    Mills holds a PhD in neuroscience; has expertise in integrative medicine, traditional medical systems, and psychoneuroimmune processes in wellness and disease; has published numerous peer-reviewed articles and book chapters on these topics; is the author of over 400 scientific publications and of the book Science, Being & Becoming  https://www.pauljmills.com/; and ORCID: https://orcid.org/0000-0003-4263-7686

  • Warren Gieck, Research Data Analyst, Austin, TX

    Gieck is an accomplished CTO specializing in medical data collection, analysis, and AI-driven software innovation; with expertise in product development, cloud solutions, and machine learning, he has spearheaded groundbreaking healthcare tools and industrial technologies; has experience in contract negotiation, database design, and automation, driving impactful advancements across diverse industries; ORCID: https://orcid.org/0009-0005-2588-4740

  • Christiane Northrup, Former Fellow of the American College of Obstetrics and Gynecology, Former Assistant Clinical Professor of Obstetrics and Gynecology at the University of Vermont College of Medicine, Portland, ME

    Northrup, MD,  is a board-certified OB/GYN with more than thirty years of clinical experience; former assistant clinical professor of OB/GYN at the University of Vermont College of Medicine; and three-time New York Times bestselling author of Women's Bodies, Women's Wisdom, The Wisdom of Menopause and Goddesses Never Age.

References

Abu Abed, O. S. (2021). Gene therapy avenues and COVID-19 vaccines. Genes & Immunity, 22(2), 120-124. https://doi.org/10.1038/s41435-021-00136-6

Alvergne, A., Kountourides, G., Argentieri, M. A., Agyen, L., Rogers, N., Knight, D., Sharp, G. C., Maybin, J. A., & Olszewska, Z. (2023). A retrospective case-control study on menstrual cycle changes following COVID-19 vaccination and disease. iScience, 26(4), 106401. https://doi.org/10.1016/j.isci.2023.106401

Anderson, N. B., Nordal, K. C., Breckler, S., Bethune, S., Ballard, D., Bufka, L., Bossolo, L., Brownawell, A., & Kelley, K. (2010). Stress in America findings. American Psychological Association. https://www.apa.org/news/press/releases/stress/2010/national-report.pdf

Argano, C., Mallaci Bocchio, R., Natoli, G., Scibetta, S., Lo Monaco, M., & Corrao, S. (2023). Protective Effect of Vitamin D Supplementation on COVID-19-Related Intensive Care Hospitalization and Mortality: Definitive Evidence from Meta-Analysis and Trial Sequential Analysis. Pharmaceuticals, 16(1), 130. https://doi.org/10.3390/ph16010130

Baena-García, L., Aparicio, V. A., Molina-López, A., Aranda, P., Cámara-Roca, L., & Ocón-Hernández, O. (2022). Premenstrual and menstrual changes reported after COVID-19 vaccination: the EVA project. Women's Health (London, England), 18, 1-8. https://doi.org/10.1177/17455057221112237

Banoun, H. (2022). Current state of knowledge on the excretion of mRNA and spike produced by anti-COVID-19 mRNA vaccines; possibility of contamination of the entourage of those vaccinated by these products. Infectious Diseases Research, 3(4). https://doi.org/10.53388/IDR20221125022

Banoun, H. (2023). mRNA: vaccine or gene therapy? Regulatory issues. [Preprint]. Qeios. https://doi.org/10.32388/WW4UEN

Bansal, S., Perincheri, S., Fleming, T., Poulson, C., Tiffany, B., Bremner, R. M., & Mohanakumar, T. (2021). Cutting edge: circulating exosomes with COVID spike protein are induced by BNT162b2 (Pfizer-BioNTech) vaccination prior to development of antibodies:a novel mechanism for immune activation by mRNA vaccines. Journal of Immunology, 207(10), 2405–2410. https://doi.org/10.4049/jimmunol.2100637

Berild, J. D., Larsen, V. B., Thiesson, E. M., Lehtonen, T., Grøsland, M., Helgeland, J., Wolhlfahrt, J., Hansen, J. V., Palmu, A. A., & Hviid, A. (2022). Analysis of thromboembolic and thrombocytopenic events after the AZD1222, BNT162b2, and MRNA-1273 covid-19 vaccines in 3 Nordic countries. JAMA Network Open, 5(6), e2217375-e2217375. https://doi.org/10.1001/jamanetworkopen.2022.17375

Blix, K., Laake, I., Juvet, L., Robertson, A. H., Caspersen, I. H., Mjaaland, S., Skodvin, S. N., Magnus, P., Feiring, B., & Trogstad, L. (2023). Unexpected vaginal bleeding and COVID-19 vaccination in nonmenstruating women. Science Advances, 9(38), eadg1391. https://doi.org/10.1126/sciadv.adg1391

Brogna, C., Cristoni, S., Marino, G., Montano, L., Viduto, V., Fabrowski, M., Lettieri, G., & Piscopo, M. (2023). Detection of recombinant Spike protein in the blood of individuals vaccinated against SARS-CoV-2: Possible molecular mechanisms. Proteomics Clinical Applications, 17(6), e2300048. https://doi.org/10.1002/prca.202300048

Butters, D., & Whitehouse, M. (2021). COVID-19 and nutriceutical therapies, especially using zinc to supplement antimicrobials. Inflammopharmacology, 29, 101-105. https://doi.org/https://doi.org/10.1007/s10787-020-00774-8

Castruita, J. A. S., Schneider, U. V., Mollerup, S., Leineweber, T. D., Weis, N., Bukh, J., Pedersen, M. S., & Westh, H. (2023). SARS-CoV-2 spike mRNA vaccine sequences circulate in blood up to 28 days after COVID-19 vaccination. APMIS: acta pathologica, microbiologica, et immunologica Scandinavica, 131(3), 128-132. https://doi.org/10.1111/apm.13294

Center for Biologics Evaluation and Research. (2013). Preclinical assessment of investigational cellular and gene therapy products. (Docket No. FDA–2012–D–1038). US Food and Drug Administration Retrieved from https://www.fda.gov/media/87564/download

Center for Biologics Evaluation and Research. (2015). Design and analysis of shedding studies for virus or bacteria-based gene therapy and oncolytic products: guidance for industry. US Food and Drug Administration, Retrieved from https://www.fda.gov/media/89036/download

Chow, M. Y., Qiu, Y., & Lam, J. K. (2020). Inhaled RNA therapy: from promise to reality. Trends in pharmacological sciences, 41(10), 715-729. https://doi.org/10.1016/j.tips.2020.08.002

Commitee for Medicinal Products for Human Use CHMP. (2006). Guideline on clinical evaluation of new vaccines. (EMEA/CHMP/VWP/164653/2005). European Medicines Agency, Retrieved from https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-clinical-evaluation-new-vaccines_en.pdf

Committee for Medicinal Products for Human Use. (2021). Assessment Report COVID-19 Vaccine Moderna. European Medicines Agency. https://www.ema.europa.eu/en/documents/assessment-report/spikevax-previously-covid-19-vaccine-moderna-epar-public-assessment-report_en.pdf

Darney, B. G., Boniface, E. R., Van Lamsweerde, A., Han, L., Matteson, K. A., Cameron, S., Male, V., Acuna, J., Benhar, E., Pearson, J. T., & Edelmann, A. (2023). Impact of coronavirus disease 2019 (COVID‐19) vaccination on menstrual bleeding quantity: An observational cohort study. BJOG: An International Journal of Obstetrics & Gynaecology, 130(7), 803-812. https://doi.org/10.1111/1471-0528.17471

Diblasi, L., Monteverde, M., Nonis, D., & Sangorrín, M. (2024). At Least 55 Undeclared Chemical Elements Found in COVID-19 Vaccines from AstraZeneca, CanSino, Moderna, Pfizer, Sinopharm and Sputnik V, with Precise ICP-MS. International Journal of Vaccine Theory, Practice, and Research, 3(2), 1367-1393. https://doi.org/https://doi.org/10.56098/mt1njj52

Edelman, A., Boniface, E. R., Male, V., Cameron, S. T., Benhar, E., Han, L., Matteson, K. A., Van Lamsweerde, A., Pearson, J. T., & Darney, B. G. (2022). Association between menstrual cycle length and covid-19 vaccination: global, retrospective cohort study of prospectively collected data. BMJ Med, 1(1), e000297. https://doi.org/10.1136/bmjmed-2022-000297

Fertig, T. E., Chitoiu, L., Marta, D. S., Ionescu, V.-S., Cismasiu, V. B., Radu, E., Angheluta, G., Dobre, M., Serbanescu, A., & Hinescu, M. E. (2022). Vaccine mRNA can be detected in blood at 15 days post-vaccination. Biomedicines, 10(7), 1538. https://doi.org/10.3390/biomedicines10071538

Flam, F. (2021, May 19, 2021). Blood clots aren’t the only vaccine side effects worth studying. Bloomberg Markets. Retrieved 06/09/23 from https://www.bloomberg.com/opinion/articles/2021-05-19/changes-in-menstruation-after-covid-19-vaccines-should-be-studied

Halma, M. T., Plothe, C., Marik, P., & Lawrie, T. A. (2023). Strategies for the Management of Spike Protein-Related Pathology. Microorganisms, 11(5), 1308. https://doi.org/10.3390/microorganisms11051308

Hanna, N., Heffes-Doon, A., Lin, X., De Mejia, C. M., Botros, B., Gurzenda, E., & Nayak, A. (2022). Detection of messenger RNA COVID-19 vaccines in human breast milk. JAMA pediatrics, 176(12), 1268-1270. https://doi.org/10.1001/jamapediatrics.2022.3581

Hanna, N., Manzano De Majia, C., Heffes-Doon, A., Lin, X., Botros, B., Gurzenda, E., Clauss-Pascarelli, C., & Nayak, A. (2023). Biodistribution of mRNA COVID-19 vaccines in human breast milk. eBioMedicine, 96(104800), 104800. https://doi.org/10.1016/j.ebiom.2023.104800

Jahanfar, S., Awang, C. H. C., Abd Rahman, R., Samsuddin, R. D., & See, C. P. (2007). Is 3α-androstenol pheromone related to menstrual synchrony? BMJ Sexual & Reproductive Health, 33(2), 116-118. https://doi.org/10.1783/147118907780254042

Kajiwara, S., Akiyama, N., Baba, H., & Ohta, M. (2023). Association between COVID-19 vaccines and the menstrual cycle in young Japanese women. Journal of Infection and Chemotherapy: official journal of the Japan Society of Chemotherapy. https://doi.org/10.1016/j.jiac.2023.01.003

Kedl, R. M., Hsieh, E. W. Y., Morrison, T. E., Samayoa-Reyes, G., Flaherty, S., Jackson, C. L., & Rochford, R. (2023). Evidence for Aerosol Transfer of SARS-CoV-2–Specific Humoral Immunity. ImmunoHorizons, 7(5), 307-309. https://doi.org/10.4049/immunohorizons.2300027

Khan, S. M., Shilen, A., Heslin, K. M., Ishimwe, P., Allen, A. M., Jacobs, E. T., & Farland, L. V. (2022). SARS-CoV-2 infection and subsequent changes in the menstrual cycle among participants in the Arizona CoVHORT study. American Journal of Obstetrics and Gynecology, 226(2), 270-273. https://doi.org/10.1016/j.ajog.2021.09.016

Krauson, A. C., FVC; Siddiquee, Z; Stone, JR. (2023). Duration of SARS-CoV-2 mRNA vaccine persistence and factors associated with cardiac involvement in recently vaccinated patients. NPJ Vaccines, 8(1), 141. https://doi.org/10.1038/s41541-023-00742-7

Lagana, A. S., Veronesi, G., Ghezzi, F., Ferrario, M. M., Cromi, A., Bizzarri, M., Garzon, S., & Cosentino, M. (2022). Evaluation of menstrual irregularities after COVID-19 vaccination: results of the MECOVAC survey. Open Medicine, 17(1), 475-484. https://doi.org/10.1515/med-2022-0452

Lauretta, R., Sansone, A., Sansone, M., Romanelli, F., & Appetecchia, M. (2019). Endocrine disrupting chemicals: effects on endocrine glands. Frontiers in endocrinology, 10, 178. https://doi.org/10.3389/fendo.2019.00178

Lee, K. M. N., Junkins, E. J., Luo, C., Fatima, U. A., Cox, M. L., & Clancy, K. B. H. (2022). Investigating trends in those who experience menstrual bleeding changes after SARS-CoV-2 vaccination. Science Advances, 8(28), eabm7201. https://doi.org/10.1126/sciadv.abm7201

Leong, E. W., & Ge, R. (2022). Lipid nanoparticles as delivery vehicles for inhaled therapeutics. Biomedicines, 10(9), 2179. https://doi.org/10.3390/biomedicines10092179

Lessans, N., Rottenstreich, A., Stern, S., Gilan, A., Saar, T. D., Porat, S., & Dior, U. P. (2022). The effect of BNT162b2 SARS-CoV-2 mRNA vaccine on menstrual cycle symptoms in healthy women. International Journal of Gynaecology and Obstetrics, 160(1), 313-318. https://doi.org/10.1002/ijgo.14356

Li, M., Al-Jamal, K. T., Kostarelos, K., & Reineke, J. (2010). Physiologically based pharmacokinetic modeling of nanoparticles. ACS nano, 4(11), 6303-6317. https://doi.org/10.1021/nn1018818

Liao, Y., Du, X., Li, J., & Lönnerdal, B. (2017). Human milk exosomes and their microRNAs survive digestion in vitro and are taken up by human intestinal cells. Molecular nutrition & food research, 61(11), 1700082. https://doi.org/https://doi.org/10.1002/mnfr.201700082

Liu, J., Li, Y., Liu, L., Hu, X., Wang, X., Hu, H., Hu, Z., Zhou, Y., & Wang, M. (2020). Infection of human sweat glands by SARS-CoV-2. Cell Discovery, 6(1), 84. https://doi.org/10.1038/s41421-020-00229-y

Lucchetti, D., Santini, G., Perelli, L., Ricciardi-Tenore, C., Colella, F., Mores, N., Macis, G., Bush, A., Sgambato, A., & Montuschi, P. (2021). Detection and characterisation of extracellular vesicles in exhaled breath condensate and sputum of COPD and severe asthma patients. European Respiratory Journal, 58(2), 2003024. https://doi.org/10.1183/13993003.03024-2020

Machhi, J., Shahjin, F., Das, S., Patel, M., Abdelmoaty, M. M., Cohen, J. D., Singh, P. A., Baldi, A., Bajwa, N., & Kumar, R. (2021). A role for extracellular vesicles in SARS-CoV-2 therapeutics and prevention. Journal of Neuroimmune Pharmacology, 16, 270-288. https://doi.org/10.1007/s11481-020-09981-0

Mikhael, S., Punjala-Patel, A., & Gavrilova-Jordan, L. (2019). Hypothalamic-pituitary-ovarian axis disorders impacting female fertility. Biomedicines, 7(1), 5. https://doi.org/10.3390/biomedicines7010005

Moderna Inc. (2018). Moderna, Inc., Amendment no. 1 to form S-1 registration statement. (Registration No. 333-228300). US Securities and Exchange Commission, Retrieved from https://www.sec.gov/Archives/edgar/data/1682852/000119312518335714/d611137ds1a.htm

Moderna Inc. (2020). Form 10-Q quarterly report for the quarterly period ended June 30, 2020 (Commission file number: 001-38753). https://www.sec.gov/Archives/edgar/data/1682852/000168285220000017/mrna-20200630.htm

Moderna Inc. (2022). A phase 3, randomized, stratified, observer-blind, placebo-controlled study to evaluate the efficacy, safety, and immunogenicity of mRNA-1273 SARS-CoV-2 vaccine in adults aged 18 years and older. (ID Number NCT04470427). clinicaltrials.gov: US National Library of Medicine, Retrieved from https://clinicaltrials.gov/ct2/show/NCT04470427?term=NCT04470427&rank=1

Mohammadi, A. H., Behjati, M., Karami, M., Abari, A. H., Sobhani-Nasab, A., Rourani, H. A., Hazrati, E., Mirghazanfari, S. M., Hadi, V., & Hadi, S. (2022). An overview on role of nutrition on COVID-19 immunity: Accumulative review from available studies. Clinical Nutrition Open Science. https://doi.org/https://doi.org/10.1016/j.nutos.2022.11.001

Muhaidat, N., Alshrouf, M. A., Azzam, M. I., Karam, A. M., Al-Nazer, M. W., & Al-Ani, A. (2022). Menstrual symptoms after COVID-19 vaccine: a cross-sectional investigation in the MENA region. International Journal of Women's Health, 14, 395-404. https://doi.org/10.2147/IJWH.S352167

National Institutes of Health. (2019). NIH guidelines for research involving recombinant or synthetic nucleic acid molecules. US Department of Health and Human Services, Retrieved from https://osp.od.nih.gov/wp-content/uploads/2019_NIH_Guidelines.htm

Our World In Data. (2023). COVID-19 vaccinations in the United States. Our World in Data. Retrieved 06/09/23 from https://ourworldindata.org/grapher/covid-vaccine-doses-by-manufacturer?time=earliest..2021-02-28&country=~USA

Pantazatos, S., & Seligmann, H. (2021). COVID vaccination and age-stratified all-cause mortality risk [Preprint]. ResearchGate. https://doi.org/10.13140/RG.2.2.28257.43366/1

Parotto, T., Thorp, J. A., Hooker, B., Mills, P. J., Newman, J., Murphy, L., Geick, W., McDyer, D. C., Stricker, R. B., Peters, S., McDonnell, M., Ray, H., & Northrup, C. (2022). COVID-19 and the surge in decidual cast shedding. The Gazette of Medical Sciences, 3(1), 107-117. https://doi.org/10.46766/thegms

Patterson, B. K., Francisco, E. B., Yogendra, R., Long, E., Pise, A., Rodrigues, H., Hall, E., Herrera, M., Parikh, P., & Guevara-Coto, J. (2022). Persistence of SARS CoV-2 S1 protein in CD16+ monocytes in post-acute sequelae of COVID-19 (PASC) up to 15 months post-infection. Frontiers in immunology, 12, 746021. https://doi.org/10.3389/fimmu.2021.746021

Pfizer Inc. (2020). A phase 1/2/3, placebo-controlled, randomized, observer-blind, dose-finding study to evaluate the safety, tolerability, immunogenicity, and efficacy of the SARS-CoV-2 RNA vaccine candidates against COVID-19 in healthy individuals. Pfizer Inc. https://web.archive.org/web/20230116215816/https://cdn.pfizer.com/pfizercom/2020-11/C4591001_Clinical_Protocol_Nov2020.pdf

Pfizer Inc. (2021). SARS-CoV-2 mRNA Vaccine (BNT162, PF-07302048). https://web.archive.org/web/20210403075739/https://www.pmda.go.jp/drugs/2021/P20210212001/672212000_30300AMX00231_I100_1.pdf

Röltgen, K., Nielsen, S., Silva, O., Younes, S., Zaslavsky, M., Costales, C., Yang, F., Wirz, O., Solis, D., Hoh, R., Wang, A., Arunachalam, P., Colburg, D., Zhao, S., Haraguchi, E., Lee, A., Shah, M., Manohar, M., Chang, I., . . . Boyd, S. (2022). Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination. Cell, 185(6), 1025-1040.e1014. https://doi.org/10.1016/j.cell.2022.01.018

Sahin, U., Karikó, K., & Türeci, Ö. (2014). mRNA-based therapeutics—developing a new class of drugs. Nature reviews Drug discovery, 13(10), 759-780. https://doi.org/10.1038/nrd4278

Salkind, N. J. (2010). Encyclopedia of Research Design (Vol. 1). Sage.

Shakoor, H., Feehan, J., Al Dhaheri, A. S., Ali, H. I., Platat, C., Ismail, L. C., Apostolopoulos, V., & Stojanovska, L. (2021). Immune-boosting role of vitamins D, C, E, zinc, selenium and omega-3 fatty acids: Could they help against COVID-19? Maturitas, 143, 1-9. https://www.maturitas.org/article/S0378-5122(20)30346-7/pdf

Solis, O., Beccari, A. R., Iaconis, D., Talarico, C., Ruiz-Bedoya, C. A., Nwachukwu, J. C., Cimini, A., Castelli, V., Bertini, R., Montopoli, M., Cocetta, V., Borocci, S., Prandi, I. G., Flavahan, K., Bahr, M., Napiorkowski, A., Chillemi, G., Ooka, M., Yang, X., . . . Michaelides, M. (2022). The SARS-CoV-2 spike protein binds and modulates estrogen receptors. Science Advances, 8(48), eadd4150. https://doi.org/doi:10.1126/sciadv.add4150

Speicher, D. J., Rose, J., Gutschi, L. M., & McKernan, K. (2023). DNA fragments detected in monovalent and bivalent Pfizer/BioNTech and Moderna modRNA COVID-19 vaccines from Ontario, Canada: Exploratory dose response relationship with serious adverse events. Preprint. https://osf.io/preprints/mjc97

Therapeutic Goods Administration. (2021). Nonclinical Evaluation Report BNT162b2 [mRNA] COVID-19 vaccine (COMIRNATY) (Submission No: PM-2020-05461-1-2). Australian Government Department of Health. https://www.tga.gov.au/sites/default/files/foi-2389-06.pdf

Trogstad, L., Juvet, L., Feiring, B., & Blix, K. (2022). Covid-19 vaccines and menstrual changes. BMJ Medicine, 1(1), e000357. https://doi.org/10.1136/bmjmed-2022-000357

Trogstad, L., Laake, I., Robertson, A., Mjaaland, S., Caspersen, I. H., Juvet, L., Magnus, P., Blix, K., & Feiring, B. (2023). Heavy bleedings and other menstrual disturbances in 18-to 30-year-old women after COVID-19 vaccination [Preprint]. SSRN(Preprint). https://doi.org/10.2139/ssrn.4326798

Trougakos, I. P., Terpos, E., Alexopoulos, H., Politou, M., Paraskevis, D., Scorilas, A., Kastritis, E., Andreakos, E., & Dimopoulos, M. A. (2022). Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis. Trends in Molecular Medicine, 28(7), 542-554. https://doi.org/10.1016/j.molmed.2022.04.007

UK Medicines & Healthcare Products Regulatory Agency. (2023, March 8, 2023). Research and analysis: coronavirus vaccine- summary of Yellow Card reporting. GOV.UK. Retrieved 06/10/23 from https://www.gov.uk/government/publications/coronavirus-covid-19-vaccine-adverse-reactions/coronavirus-vaccine-summary-of-yellow-card-reporting#yellow-card-reports

US Centers for Disease Control and Prevention. (2021). Understanding mRNA COVID-19 Vaccines. Retrieved 1/14/2024 from https://web.archive.org/web/20210731211219/https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/mrna.html

US Department of Health and Human Services. (2020). Explaining Operation Warp Speed. HHS.gov: HHS.gov Retrieved from https://web.archive.org/web/20200816061236/https://www.hhs.gov/sites/default/files/fact-sheet-operation-warp-speed.pdf

US Food and Drug Administration. (2020). Emergency use authorization (EUA) for an unapproved product review memorandum: Moderna. (Application number: 27073). Food and Drug Administration Retrieved from https://fda.report/media/144673/Moderna.pdf

US Food and Drug Administration. (2020b). Emergency use authorization (EUA) for an unapproved product review memorandum: Pfizer-BioNTech. (Application number: 27034). US Food and Drug Administration Retrieved from https://www.fda.gov/media/144416/download

US Food and Drug Administration. (2020c, 12/18/2020). FDA takes additional action in fight against COVID-19 by issuing emergency use authorization for second COVID-19 vaccine. https://www.fda.gov/news-events/press-announcements/fda-takes-additional-action-fight-against-covid-19-issuing-emergency-use-authorization-second-covid

Wang, R., Song, B., Wu, J., Zhang, Y., Chen, A., & Shao, L. (2018). Potential adverse effects of nanoparticles on the reproductive system. International journal of nanomedicine, 13, 8487-8506. https://doi.org/10.2147/IJN.S170723

Wang, S., Mortazavi, J., Hart, J. E., Hankins, J. A., Katuska, L. M., Farland, L. V., Gaskins, A. J., Wang, Y. X., Tamimi, R. M., Terry, K. L., Rich-Edwards, J. W., Missmer, S. A., & Chavarro, J. E. (2022). A prospective study of the association between SARS-CoV-2 infection and COVID-19 vaccination with changes in usual menstrual cycle characteristics. American Journal of Obstetrics and Gynecology, 227(5), 739.e731-739.e711. https://doi.org/10.1016/j.ajog.2022.07.003

Wong, K. K., Heilig, C. M., Hause, A., Myers, T. R., Olson, C. K., Gee, J., Marquez, P., Strid, P., & Shay, D. K. (2022). Menstrual irregularities and vaginal bleeding after COVID-19 vaccination reported to v-safe active surveillance, USA in December, 2020–January, 2022: an observational cohort study. The Lancet Digital Health, 4(9), e667-e675. https://doi.org/10.1016/S2589-7500(22)00125-X

Yeo, K. T., Chia, W. N., Tan, C. W., Ong, C., Yeo, J. G., Zhang, J., Poh, S. L., Lim, A. J. M., Sim, K. H. Z., & Sutamam, N. (2022). Neutralizing activity and SARS-CoV-2 vaccine mRNA persistence in serum and breastmilk after BNT162b2 vaccination in lactating women. Frontiers in immunology, 12, 783975. https://doi.org/10.3389/fimmu.2021.783975

Yeo, W. S., & Ng, Q. X. (2021). Passive inhaled mRNA vaccination for SARS-Cov-2. Medical Hypotheses, 146, 110417. https://doi.org/https://doi.org/10.1016/j.mehy.2020.110417

Zhang, H., Leal, J., Soto, M. R., Smyth, H. D., & Ghosh, D. (2020). Aerosolizable lipid nanoparticles for pulmonary delivery of mRNA through design of experiments. Pharmaceutics, 12(11), 1042. https://doi.org/10.3390/pharmaceutics12111042

cover image for Volume 3, Issue 2

Downloads

Published

2024-12-07

Issue

Vol. 3 No. 2 (2024): Injuries, Causes, and Treatments, Part 2

Section

Articles

License

Copyright (c) 2024 Sue E. Peters, Jill Newman , Heather Ray, James A. Thorp, Tiffany Parotto, Brian Hooker, Dan McDyer, Leonard Murphy, Ralph B Stricker, Maureen McDonnell, Paul J. Mills, Warren Gieck, Christiane Northrup

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

The copyright for materials in this journal, IJVTPR, is owned by the author. The author, however, grants first right of publication to the journal, IJVTPR and assures the editorial staff of the journal that the work submitted has not simultaneously been submitted to any other journal, nor is it under consideration for publication by any other journal. If any portion of the work submitted has appeared elsewhere, the quoted material is properly cited and credit is given to the original publisher. The submitting author (or the principal and corresponding author of the work) also assures the editors  of IJVTPR that he or she has obtained all required written permissions from any quoted authors or publishers of quoted materials. The submitting author also agrees to hold IJVTPR and its editorial staff harmless from any infractions of copyright law that may be discovered at any time in the future in the submitted work. The author assures the editorial staff at IJVTPR that none of the work submitted is plagiarized, and that any recycled or precycled material by the author is identified as such with proper credits in the text to any other parties holding a copyright interest in the quoted material.

How to Cite

Menstrual Abnormalities Strongly Associated with Proximity to COVID-19 Vaccinated Individuals. (2024). International Journal of Vaccine Theory, Practice, and Research , 3(2), 1435-1461. https://doi.org/10.56098/tp99wn15

Similar Articles

1-10 of 63

You may also start an advanced similarity search for this article.